The project "RIBOLUTION - integrated platform for the identification and validation of innovative RNA-based biomarkers for personalized medicine" is sponsored by the Fraunhofer Future Foundation Research Network.
The objective of the Fraunhofer Foundation project "RIBOLUTION" is the identification of novel diagnostic indicators for diseases such as COPD and prostate cancer. In this case, the project concentrates to a new class of molecules, the so-called non-(protein)-encoding ribonucleic acids (ncRNAs). Previous studies show that ncRNAs constitute the central level of the cell biological control in complex organisms and regulate diverse cellular processes such as transcription, translation, RNA editing, or chromatin epigenetic processes. It is believed, that they play a crucial role in disease development and thus have a particularly high diagnostic biomarker potential.